FDA nod for Breyanzi as first CAR T therapy for r/r marginal zone lymphoma

Biotechnology News · FDA nod for Breyanzi as first CAR T therapy for r/r marginal zone lymphoma. FDA nod for Breyanzi as first CAR T therapy for r/r …